Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters
Authors:
Open Access
- 18 April 2022
- journal article
- research article
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 11 (1) , 1103-1114
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a pandemic. As immunity to endemic human coronaviruses (i.e. NL63 or OC43) wanes leading to re-infection, it was unknown if SARS-CoV-2 immunity would also decline permitting repeat infections. Recent case reports confirm previously infected individuals can become re-infected; however, re-infection may be due to heterogeneity in the initial infection or the host immune response, or may be the result of infection with a variant strain that escapes pre-existing immunity. To control these variables, we utilized the Syrian hamster model to evaluate the duration of immunity and susceptibility to re-infection with SARS-CoV-2. Hamsters were given a primary mock or SARS-CoV-2 infection (culture media or 105 TCID50 USA/WA1/2020 isolate, respectively). Mock and SARS-CoV-2 infected hamsters were then given a secondary SARS-CoV-2 infection at 1, 2, 4, or 6 months post-primary infection (n = 14/time point/group). After the primary SARS-CoV-2 infection, hamsters developed anti-spike protein IgG, IgA, and neutralizing antibodies, and these antibodies were maintained for at least 6 months. Upon secondary SARS-CoV-2 challenge, previously SARS-CoV-2 infected animals were protected from weight loss, while all previously mock-infected animals became infected and lost weight. Importantly, despite having high titres of antibodies, one SARS-CoV-2 infected animal re-challenged at 4 months had a breakthrough infection with replicating virus in the upper and lower respiratory tract. These studies demonstrate immunity to SARS-CoV-2 is maintained for 6 months; however, protection may be incomplete and, even in the presence of high antibody titres, previously infected hosts may become re-infected.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (HHSN272201400004C)
- NIAID Centers of Excellence for Influenza Research and Surveillance, CEIRS
- National Institute of Food and Agriculture (4605)
- Yerkes Regional Primate Research Center (P51 OD011132)
This publication has 33 references indexed in Scilit:
- Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoproteinGenome Medicine, 2020
- Age-Dependent Progression of SARS-CoV-2 Infection in Syrian HamstersViruses, 2020
- Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure developmentProceedings of the National Academy of Sciences, 2020
- Pathogenesis and transmission of SARS-CoV-2 in golden hamstersNature, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and TransmissibilityClinical Infectious Diseases, 2020
- Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnessesJournal of Medical Virology, 2020
- Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in GuangzhouPLOS ONE, 2018
- Prevalence and genetic diversity analysis of human coronaviruses among cross-border childrenVirology Journal, 2017
- Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR MethodJournal of Clinical Microbiology, 2010